A 35-year-old female with iron deficiency anemia presents with worsening fatigue, increased shortness of breath, and new onset mild chest discomfort. Her recent lab results show a hemoglobin level of 9.0 g/dL and low serum ferritin and transferrin saturation. An EKG shows sinus tachycardia. Which of the following interventions should the nurse prioritize to address the patient's current symptoms and prevent further complications?

D) Refer for a gastroenterology consultation to rule out chronic blood loss

A) Increase oral iron supplementation dosage

B) Administer intravenous iron therapy

C) Encourage a high-iron diet and monitor symptoms

D) Refer for a gastroenterology consultation to rule out chronic blood loss

A patient with worsening iron deficiency anemia is experiencing increased fatigue and shortness of breath with minimal exertion. Laboratory findings reveal a hemoglobin level of 9.0 g/dL and a serum ferritin of 8 ng/mL. Which nursing intervention is most appropriate to address the underlying cause of the patient's anemia?

C) Collaborate with the healthcare provider to schedule a gastroenterology consultation for possible endoscopy.

A) Encourage the patient to increase dietary iron intake.

B) Educate the patient on the importance of adherence to oral iron supplements.

C) Collaborate with the healthcare provider to schedule a gastroenterology consultation for possible endoscopy.

D) Administer oxygen therapy to alleviate shortness of breath.

A patient with iron deficiency anemia due to a newly diagnosed bleeding duodenal ulcer is receiving intravenous iron therapy. Which nursing intervention is most important to implement to ensure the effectiveness of the treatment plan?

C) Administer proton pump inhibitors as prescribed to aid in ulcer healing.

A) Monitor for signs of hypersensitivity during iron infusion.

B) Educate the patient on the importance of dietary iron intake.

C) Administer proton pump inhibitors as prescribed to aid in ulcer healing.

D) Encourage the patient to engage in regular physical activity to improve circulation.

A patient with iron deficiency anemia and a recent diagnosis of a bleeding duodenal ulcer is to begin intravenous iron therapy. As the nurse, what will be your primary assessment priority before initiating the IV iron treatment?

B) Checking for a history of allergies to iron preparations or any signs of hypersensitivity.

A) Assessing the patient's blood pressure to ensure there is no orthostatic hypotension.

B) Checking for a history of allergies to iron preparations or any signs of hypersensitivity.

C) Evaluating the patient's dietary intake to ensure they are consuming enough iron-rich foods.

D) Monitoring the patient's fluid balance to prevent any potential overhydration.

A patient receiving intravenous iron therapy and proton pump inhibitors for anemia due to peptic ulcer disease reports fatigue and shortness of breath. Her hemoglobin is 9.0 g/dL and hematocrit is 27%. Which additional assessment finding would most likely indicate ongoing gastrointestinal blood loss as a contributing factor to her symptoms?

B) Positive fecal occult blood test

A) Elevated serum ferritin levels

B) Positive fecal occult blood test

C) Decreased reticulocyte count

D) Increased mean corpuscular volume (MCV)

A patient with anemia secondary to peptic ulcer disease is undergoing intravenous iron therapy and proton pump inhibitor treatment. Two weeks into treatment, the patient presents with increased fatigue, shortness of breath, and a marginally improved hemoglobin level. Considering these findings, what is the most appropriate initial nursing intervention?

C) Collaborate with the healthcare provider to evaluate the need for additional diagnostic testing.

A) Increase the frequency of vital signs monitoring to every hour.

B) Educate the patient on dietary modifications to enhance iron absorption.

C) Collaborate with the healthcare provider to evaluate the need for additional diagnostic testing.

D) Administer an additional dose of intravenous iron to boost hemoglobin levels.

A patient with a history of peptic ulcer disease is not responding adequately to iron therapy and continues to exhibit signs of anemia. The healthcare team is considering additional diagnostic tests. Which nursing intervention is most appropriate to prioritize for this patient at this time?

B) Facilitate a consultation with a dietitian to assess the patient's nutritional intake and malabsorption issues.

A) Educate the patient about the importance of a gluten-free diet to address potential celiac disease.

B) Facilitate a consultation with a dietitian to assess the patient's nutritional intake and malabsorption issues.

C) Prepare the patient for a blood transfusion to quickly improve hemoglobin levels.

D) Administer the newly prescribed H2 receptor antagonist to promote gastric mucosal protection.

A patient with a history of peptic ulcer disease is being treated with a potent proton pump inhibitor and a H2 receptor antagonist. Despite these interventions, her laboratory results show persistent anemia and slightly elevated blood pressure. Which of the following actions should the nurse prioritize to further assist in managing this patient's condition?

D) Suggest the healthcare provider consider testing for celiac disease or Helicobacter pylori infection.

A) Encourage the patient to maintain a high-protein diet to improve hemoglobin levels.

B) Monitor for signs of gastrointestinal bleeding and report any changes immediately.

C) Educate the patient on the importance of medication adherence to prevent ulcer recurrence.

D) Suggest the healthcare provider consider testing for celiac disease or Helicobacter pylori infection.

A patient with anemia and a positive test for Helicobacter pylori infection is being treated with clarithromycin, amoxicillin, and a proton pump inhibitor (PPI). Despite treatment, the patient's hemoglobin level has only modestly improved. Which nursing intervention should be prioritized to enhance the patient's response to the current treatment regimen?

A) Encourage the patient to increase intake of vitamin C-rich foods.

B) Advise the patient to take iron supplements with meals to enhance absorption.

C) Recommend the patient avoid dairy products to improve antibiotic efficacy.

D) Suggest the addition of NSAIDs for pain management to improve comfort.

A patient being treated for H. pylori infection with clarithromycin, amoxicillin, and a PPI is experiencing mild gastrointestinal disturbances. As a nurse, what is the most appropriate action to take to help alleviate the patient's symptoms while continuing their treatment?

B) Encourage the patient to take the medication with food to minimize GI upset.

A) Discontinue the antibiotics immediately and consult the physician.

B) Encourage the patient to take the medication with food to minimize GI upset.

C) Advise the patient to take an over-the-counter antacid in addition to the PPI.

D) Suggest reducing the dosage of the antibiotics until symptoms improve.

iron deficiency anemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Iron deficiency anemia occurs when there is insufficient iron to produce hemoglobin, the oxygen-carrying component of red blood cells. This leads to reduced oxygen delivery to tissues, causing fatigue and pallor.

• Secondary mechanism: Iron absorption issues often arise from dietary insufficiency, malabsorption disorders (such as celiac disease), or chronic blood loss (e.g., gastrointestinal bleeding), further depleting iron stores and exacerbating anemia.

• Key complication: Chronic iron deficiency can lead to compensatory cardiovascular changes, such as tachycardia, as the body attempts to maintain adequate oxygen delivery despite reduced hemoglobin levels.

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: Chronic fatigue, previous episodes of iron deficiency anemia, hypothyroidism

• Current medications: Levothyroxine 75 mcg daily, ferrous sulfate 325 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and shortness of breath

• Key symptoms: Dizziness, palpitations, pale skin, brittle nails

• Vital signs: Blood pressure 108/65 mmHg, heart rate 102 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

Change in Patient Status:

During a follow-up visit one week after the initial presentation, the patient reports worsening fatigue and an increase in shortness of breath with minimal exertion. Upon physical examination, the patient's pallor appears more pronounced, and she continues to experience palpitations. Vital signs now reveal a blood pressure of 102/60 mmHg, heart rate of 110 bpm, and respiratory rate of 24 breaths per minute, indicating further cardiovascular strain as the body attempts to compensate for ongoing anemia. The patient also reports new onset of mild chest discomfort, which raises concerns about potential cardiac involvement given her persistent tachycardia and reduced blood pressure.

To further evaluate, a repeat complete blood count (CBC) and iron studies are ordered, revealing a hemoglobin level of 9.0 g/dL, hematocrit of 28%, serum ferritin of 8 ng/mL, and a transferrin saturation of 10%, all indicating worsening iron deficiency anemia. Additionally, an EKG is performed to assess the chest discomfort and palpitations, showing sinus tachycardia with no acute ST-T changes, suggesting the tachycardia is likely secondary to the anemia rather than a primary cardiac event.

Given these findings, the clinical reasoning process must consider potential underlying causes of her deteriorating status, such as gastrointestinal bleeding or malabsorption, which could be contributing to her refractory anemia despite adherence to oral iron therapy. The decision is made to refer the patient for a gastroenterology consultation and possible endoscopy to rule out sources of chronic blood loss. This strategic approach aims to address the root cause of the anemia and prevent further complications, while also considering the need for more aggressive iron supplementation or alternative routes of administration if oral therapy remains ineffective.

Section 2

New Diagnostic Results:

Following the gastroenterology consultation, an upper endoscopy is conducted to investigate potential sources of chronic blood loss contributing to the patient's worsening iron deficiency anemia. The procedure reveals the presence of multiple gastric erosions and a small bleeding ulcer in the proximal duodenum, consistent with peptic ulcer disease. Biopsies are taken to evaluate for Helicobacter pylori infection, a common cause of such ulcers, which could be a significant factor in the patient's ongoing blood loss. Additionally, a colonoscopy is performed to rule out lower gastrointestinal bleeding, yielding normal results with no evidence of polyps or other abnormalities.

Meanwhile, the patient's laboratory results continue to demonstrate the severity of her condition. Her hemoglobin level has now decreased to 8.5 g/dL, and her hematocrit to 26%, indicating further decline. Serum iron is measured at 30 µg/dL, with a total iron-binding capacity (TIBC) of 450 µg/dL, reinforcing the diagnosis of iron deficiency anemia. Given the inadequate response to oral iron supplementation, these findings suggest the need for a more aggressive treatment approach. The decision is made to initiate intravenous iron therapy to more effectively replenish the patient's iron stores and improve her hematological status.

This new information provides critical insights into the underlying etiology of the patient's anemia, allowing for targeted intervention. The discovery of the bleeding ulcer necessitates concurrent management with proton pump inhibitors to facilitate ulcer healing and potential eradication therapy if H. pylori is confirmed. Through these combined efforts, the aim is to stabilize the patient's condition, improve her symptoms, and prevent further cardiac strain, while continuing to monitor her response to the revised treatment plan.

Section 3

As the patient begins intravenous iron therapy and proton pump inhibitor treatment, her condition shows initial signs of stabilization. However, two weeks into the revised treatment plan, she presents with new symptoms of fatigue and shortness of breath, which are more pronounced than her baseline level. A repeat complete blood count (CBC) reveals that her hemoglobin has only marginally improved to 9.0 g/dL, and her hematocrit remains low at 27%. Despite the ongoing intravenous iron therapy, her serum ferritin levels rise only slightly, indicating that her iron stores are not replenishing as expected.

Upon physical examination, the patient exhibits mild tachycardia with a heart rate of 105 beats per minute, and her blood pressure is slightly elevated at 140/90 mmHg. Auscultation of the chest reveals a soft systolic murmur indicative of increased cardiac workload due to persistent anemia. The patient also reports new-onset epigastric pain and nausea, raising concerns for potential complications related to her peptic ulcer disease. In light of these findings, further clinical reasoning is required to assess the adequacy of her current treatment regimen and to explore additional potential causes for her symptoms.

Given the incomplete response to treatment and the emergence of new symptoms, the healthcare team considers the possibility of ongoing occult blood loss or another source of malabsorption. Additional diagnostic testing, including a fecal occult blood test and repeat endoscopic evaluation, is scheduled to further investigate these possibilities. The team also contemplates the need for more aggressive ulcer management and considers whether a change in medication, such as a different proton pump inhibitor or the addition of a H2 receptor antagonist, might better facilitate ulcer healing. This comprehensive approach aims to address the underlying causes of the patient's anemia, improve her overall condition, and prevent further complications.

Section 4

Following the decision to conduct further diagnostic testing, the fecal occult blood test returns positive, suggesting the presence of gastrointestinal bleeding. This finding correlates with the patient's persistent anemia and prompts the healthcare team to prioritize a repeat endoscopic evaluation to identify the bleeding source. During the endoscopy, a small but actively bleeding gastric ulcer is discovered, which had previously gone unnoticed. This ulcer is presumed to be the primary contributor to the ongoing blood loss and inadequate response to iron therapy.

In response to these findings, the medical team decides to adjust the patient's treatment plan to more effectively address the peptic ulcer and associated bleeding. A switch is made from her current proton pump inhibitor (PPI) to a stronger, more potent PPI, and a H2 receptor antagonist is added to the regimen to enhance gastric mucosal protection. Additionally, the patient is placed on a strict dietary regimen to minimize gastric irritation and promote healing. The team also considers the potential need for a blood transfusion to rapidly improve her hemoglobin levels and alleviate the symptoms of fatigue and shortness of breath.

Despite these interventions, the patient's follow-up labs after a week show only a slight improvement in hemoglobin to 9.5 g/dL, and her hematocrit remains low at 28%. Her vital signs reveal a heart rate that has decreased slightly to 98 beats per minute, but her blood pressure remains elevated at 138/88 mmHg. While the bleeding appears to have been addressed, these findings suggest that her anemia may have multifactorial causes, possibly including malabsorption issues. The healthcare team begins to explore other potential factors, such as celiac disease or Helicobacter pylori infection, that might be contributing to her condition and hindering her recovery. These considerations pave the way for further diagnostic testing and a comprehensive review of her treatment plan to optimize her care and prevent further complications.

Section 5

As the healthcare team continues to address the underlying causes of the patient's anemia, a decision is made to test for Helicobacter pylori infection, given its known association with peptic ulcers and potential impact on iron absorption. The results return positive, indicating an active H. pylori infection. This finding elucidates a significant factor in the patient's ongoing anemia and suboptimal response to iron therapy, as the infection can exacerbate ulcer formation and hinder nutrient absorption.

In light of these new diagnostic results, the treatment plan is adjusted to include a combination of antibiotics, specifically clarithromycin and amoxicillin, along with the continued use of a potent PPI to eradicate the H. pylori infection and promote ulcer healing. The addition of these antibiotics necessitates careful monitoring of the patient for potential side effects, such as gastrointestinal disturbances or allergic reactions. In conjunction with these changes, the patient is advised to maintain her dietary modifications and avoid NSAIDs, which could worsen gastric irritation.

Following the initiation of this targeted therapy, the patient begins to report a modest improvement in her symptoms, such as reduced fatigue and a slight increase in energy levels. However, her laboratory results at the two-week follow-up reveal that her hemoglobin has only increased to 10.2 g/dL, and her hematocrit remains at 30%. Although these changes indicate a positive trend, the slow progression underscores the need for continued vigilance and further evaluation of her nutritional status and potential malabsorption issues. The team considers additional tests, such as endoscopic biopsy for celiac disease, to ensure comprehensive management of her condition and prevent further complications.